These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 387961)

  • 21. Selective suppression of humoral and cellular immunity with cytosine arabinoside.
    Griswold DE; Heppner GH; Calabresi P
    Cancer Res; 1972 Feb; 32(2):298-301. PubMed ID: 4550745
    [No Abstract]   [Full Text] [Related]  

  • 22. The key role of Lyt-1+ cells in skin graft rejection in the mouse.
    Loveland B; Ceredig R; Hogarth M; McKenzie I
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1079-81. PubMed ID: 7022917
    [No Abstract]   [Full Text] [Related]  

  • 23. Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide.
    Belehu A; Poulter LW; Turk JL
    Clin Exp Immunol; 1976 Apr; 24(1):125-32. PubMed ID: 949870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of immunologic memory in mice following treatment with oxisuran.
    Fox AE; Freedman HH
    J Immunol; 1974 Apr; 112(4):1394-400. PubMed ID: 4592600
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunological responses in the mole rat (Spalax leucodon). I. Antibody production, delayed hypersensitivity and lymphatic tissue.
    Janković BD; Paunović VR
    Ann Immunol (Paris); 1973 Feb; 124(1):133-52. PubMed ID: 4269227
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonspecific delayed cutaneous hypersensitivity suppression produced by skin grafting.
    Burdick JF; Leipziger LS
    Transplantation; 1980 May; 29(5):428-9. PubMed ID: 6990571
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical immunological variants of leishmaniasis].
    Shuĭkina EE
    Med Parazitol (Mosk); 1980; 49(3):75-81. PubMed ID: 6993910
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental aspects of delayed hypersensitivity.
    Berkel AI
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:147-51. PubMed ID: 4277433
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
    Wieczorek Z; Słoń J; Siemion IZ
    Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between cellular manifestations of allograft response and graft rejection times.
    Viklický V; Polácková M
    Folia Biol (Praha); 1974; 20(2):125-32. PubMed ID: 4140110
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of T-cell-mediated immune responses by sodium cyanate.
    Nehlsen SL; Lalezari P
    Transplant Proc; 1977 Mar; 9(1):997-1000. PubMed ID: 325836
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypersensitivity based on the immunological reactions (immediate type--delayed type)].
    Goetze E
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):476-9. PubMed ID: 4255947
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of baclofen on characteristics of the cellular immune response].
    Tiurenkov IN; Samotrueva MA; Ovcharova AN
    Eksp Klin Farmakol; 2008; 71(3):43-5. PubMed ID: 18652257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
    Lowry RP; Gurley KE
    Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cellular immune capacity of mice with transplanted lymphoid leukaemia.
    Boranic M; Poljak-Blazi M
    Biomedicine; 1976 Jun; 25(4):141-4. PubMed ID: 782579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shortened survival of skin allografts in mice after treatment with pus lyophilizates.
    Floersheim GL; Logara-Kalantzis A
    Clin Exp Immunol; 1973 Jan; 13(1):149-52. PubMed ID: 4587498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro quantitative determination of the cellular response to skin allografts in mice].
    Degiovanni G
    C R Seances Soc Biol Fil; 1972; 166(4):722-7. PubMed ID: 4568591
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of antiplasma cell sera on the primary immune response.
    Harris NS; Jagarlamoody SM; McKhann CF; Najarian JS
    J Immunol; 1972 Apr; 108(4):958-64. PubMed ID: 4554015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.